prikaz prve stranice dokumenta Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review
  Preuzmi
PDF 738.3 KB
Znanstveni rad - Pregledni rad
Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review
Journal of Chemotherapy, 31 (2019), 6; 354-358. https://doi.org/10.1080/1120009X.2019.1603797
Krajcar, Nina; Marić, Lorna Stemberger; Šarić, Dalibor; Milić, Neven; Tešović, Goran

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Krajcar, N., Marić, L. S., Šarić, D., Milić, N. i Tešović, G. (2019). Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review. Journal of Chemotherapy, 31. (6), 354-358. doi: 10.1080/1120009X.2019.1603797

Krajcar, Nina, et al. "Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review." Journal of Chemotherapy, vol. 31, br. 6, 2019, str. 354-358. https://doi.org/10.1080/1120009X.2019.1603797

Krajcar, Nina, Lorna Stemberger Marić, Dalibor Šarić, Neven Milić i Goran Tešović. "Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review." Journal of Chemotherapy 31, br. 6 (2019): 354-358. https://doi.org/10.1080/1120009X.2019.1603797

Krajcar, N., et al. (2019) 'Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review', Journal of Chemotherapy, 31(6), str. 354-358. doi: 10.1080/1120009X.2019.1603797

Krajcar N, Marić LS, Šarić D, Milić N, Tešović G. Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review. Journal of Chemotherapy [Internet]. 31.10.2019. [pristupljeno 04.05.2024.];31(6):354-358. doi: 10.1080/1120009X.2019.1603797

N. Krajcar, L. S. Marić, D. Šarić, N. Milić i G. Tešović, "Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review", Journal of Chemotherapy, vol. 31, br. 6, str. 354-358, Listopad 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:117427. [Citirano: 04.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:117427
Podaci o radu
Naslov (engleski)Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review
AutorNina Krajcar
AutorLorna Stemberger Marić
AutorDalibor Šarić
AutorNeven Milić
AutorGoran Tešović
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Infective endocarditis (IE) is uncommon in children, affecting predominantly subjects with congenital heart disease (CHD) and patients with indwelling central lines. The principles of antibiotic treatment in paediatric population are similar to those in adults. Prolonged intravenous administration of bactericidal rather than bacteriostatic agents is preferred. Outpatient intravenous therapy after initial treatment in the hospital may be considered only in selected patients. Partial oral treatment has been described in cases of left-sided, uncomplicated IE caused by common pathogens in adult patients. There are no guidelines or trials in paediatric population regarding switching therapy from intravenous to oral route. We present two cases of IE in children caused by uncommon pathogenic bacteria (Abiotrophia defectiva and Haemophilus parainfluenzae) successfully treated with oral third-generation cephalosporin - cefpodoxime proxetil after initial intravenous therapy. This paper provides observations on different therapeutic approach for IE in children as well as another potential use of cefpodoxime proxetil.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaJournal of Chemotherapy
Brojčani podacivol. 31, br. 6, str. 354-358
p-ISSN1120-009X
DOIhttps://doi.org/10.1080/1120009X.2019.1603797
URN:NBNurn:nbn:hr:105:117427
Datum objave publikacije2019-10-31
URL dokumentahttps://doi.org/10.1080/1120009X.2019.1603797
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:41:39